Triazole Compounds Useful As Protein Kinase Inhibitors

Details for Australian Patent Application No. 2006201230 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Golec, Julian M. C.; Knegtel, Ronald; Charrieir, Jean-Damien; Bebbington, David; Li, Pan; Binch, Haley

Agent Cullen & Co

Pub. Number AU-B-2006201230

Parent 2001296875

Filing date 21 March 2006

Wipo publication date 13 April 2006

Acceptance publication date 11 September 2008

International Classifications

C07D 403/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

13 April 2006 Application Open to Public Inspection

  Published as AU-B-2006201230

13 April 2006 Complete Application Filed

11 September 2008 Application Accepted

  Published as AU-B-2006201230

25 September 2008 Corrigenda

  Applications Accepted - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2006201230, under INID(72), correct the coinventor name to Charrier, Jean-Damien

22 January 2009 Standard Patent Sealed

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006201231-An electrical lead

2006201229-Pyrazole Compounds Useful as Protein Kinase Inhibitors